Deutsche Bank Ag\ Spero Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

  • $287 Billion
  • Q3 2025

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$0.74 - $7.44 $10,274 - $103,304
-13,885 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$7.87 - $15.15 $13,048 - $25,118
-1,658 Reduced 10.67%
13,885 $121,000
Q4 2021

Feb 11, 2022
BUY
$13.09 - $18.77 $10,210 - $14,640
780 Added 5.28%
15,543 $249,000
Q3 2021

Nov 04, 2021
SELL
$13.03 - $19.51 $5,889 - $8,818
-452 Reduced 2.97%
14,763 $272,000
Q2 2021

Aug 11, 2021
BUY
$12.22 - $15.79 $15,421 - $19,926
1,262 Added 9.04%
15,215 $213,000
Q1 2021

May 13, 2021
SELL
$13.23 - $21.48 $16,391 - $26,613
-1,239 Reduced 8.16%
13,953 $205,000
Q4 2020

Feb 16, 2021
BUY
$11.65 - $22.07 $80,571 - $152,636
6,916 Added 83.57%
15,192 $294,000
Q3 2020

Nov 12, 2020
BUY
$8.96 - $14.12 $6,737 - $10,618
752 Added 9.99%
8,276 $92,000
Q2 2020

Aug 13, 2020
BUY
$7.27 - $14.18 $29,479 - $57,499
4,055 Added 116.89%
7,524 $102,000
Q1 2020

May 14, 2020
SELL
$5.27 - $10.41 $23,509 - $46,439
-4,461 Reduced 56.25%
3,469 $28,000
Q4 2019

Feb 14, 2020
BUY
$9.46 - $12.16 $47,725 - $61,347
5,045 Added 174.87%
7,930 $76,000
Q3 2019

Nov 14, 2019
SELL
$9.01 - $12.55 $43,716 - $60,892
-4,852 Reduced 62.71%
2,885 $30,000
Q2 2019

Aug 14, 2019
SELL
$10.25 - $14.36 $22,724 - $31,836
-2,217 Reduced 22.27%
7,737 $88,000
Q1 2019

May 15, 2019
SELL
$6.26 - $13.31 $6,742 - $14,334
-1,077 Reduced 9.76%
9,954 $127,000
Q4 2018

Feb 14, 2019
SELL
$5.69 - $11.28 $47,175 - $93,522
-8,291 Reduced 42.91%
11,031 $67,000
Q3 2018

Dec 21, 2021
BUY
$9.69 - $17.79 $21,666 - $39,778
2,236 Added 13.09%
19,322 $203,000
Q3 2018

Nov 14, 2018
BUY
$9.69 - $17.79 $43,721 - $80,268
4,512 Added 35.88%
17,086 $179,000
Q2 2018

Apr 21, 2020
BUY
$10.41 - $17.85 $21,069 - $36,128
2,024 Added 19.18%
12,574 $184,000
Q2 2018

Aug 14, 2018
BUY
$10.41 - $17.85 $28,346 - $48,605
2,723 Added 34.79%
10,550 $154,000
Q1 2018

Oct 18, 2019
BUY
$9.96 - $14.61 $13,754 - $20,176
1,381 Added 21.42%
7,827 $110,000
Q1 2018

May 15, 2018
SELL
$9.96 - $14.61 $68,196 - $100,034
-6,847 Reduced 51.51%
6,446 $91,000
Q4 2017

Feb 14, 2018
BUY
$10.43 - $14.75 $138,645 - $196,071
13,293
13,293 $155,000

About Spero Therapeutics, Inc.

SPRO Quotes by TradingView
  • Ticker SPRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,067,500
  • Market Cap $84.5M
  • Description
  • Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...
More about SPRO
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email